Key result
This review discusses the history of bradyarrhythmia treatment and the ongoing development of gene and cell therapies aimed at achieving a stable, hardware-free cardiac rhythm.
This review outlines the historical context of electronic pacemakers and the future potential of gene and cell therapies to create biological pacemakers.
Remains investigational and should not alter current pacemaker use; leaves open the prospect of hardware-free rhythm control with further research.
The prevention and treatment of life-threatening bradyarrhythmias have been revolutionized in the last half century by electronic pacemakers. Because this represents a palliative therapy, attempts have begun to effect a cure with the novel tools of gene and cell therapy. Over time, the strategies used have coalesced to focus on achieving a stable and autonomically responsive cardiac rhythm in a setting that ultimately would require no implanted hardware. In this report, we review the history of the disease process being treated, approaches now in progress, and the demands that must be met if biological therapies are to be successful.
No takes yet. Share an insight, caveat, or question.
Rosen et al. (2008) conducted a review in Bradyarrhythmias. Biological therapies (gene and cell therapy) was evaluated. This review discusses the history of bradyarrhythmia treatment and the ongoing development of gene and cell therapies aimed at achieving a stable, hardware-free cardiac rhythm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: